CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Por um escritor misterioso
Descrição
SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2 - ScienceDirect
SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell - ScienceDirect
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies: Molecular Therapy
Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
Frontiers The role of DC-SIGN as a trans-receptor in infection by MERS-CoV
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Frontiers The role of DC-SIGN as a trans-receptor in infection by MERS-CoV
Full article: Immunouniverse of SARS-CoV-2
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
IJMS, Free Full-Text
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling
Frontiers SARS-CoV-2 and the Host Cell: A Tale of Interactions
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
de
por adulto (o preço varia de acordo com o tamanho do grupo)
